Schedule 13G ownership disclosure

BioPlus Acquisition Corp.

Security class unavailable · CUSIP: G11217117

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,791,845
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-23-003019
Form type
SC 13G/A
Filer
BioPlus Acquisition Corp.
CIK
CIK 1856653
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub